FIGURE

Fig. 4

ID
ZDB-FIG-210303-78
Publication
Dapueto et al., 2020 - A novel nitroalkene vitamin E analogue inhibits the NLRP3 inflammasome and protects against inflammation and glucose intolerance triggered by obesity
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

Fig. 4. NATx0 inhibits acute NLRP3 activation and IL-1β production in vivo. C57BL/6 mice were injected intraperitoneally (i.p) with 20 mg/kg NATx0 or vehicle (DMSO) 1 h before i.p. injection of 10 mg/kg LPS Escherichia coli or PBS. After 2 h mice were killed and levels of IL-1β in serum and peritoneum was measured by ELISA. One-way ANOVA with Bonferroni's multiple comparison test: *** <0.0001; **** <0.0001; ** = 0.0004 (n = 7 per group).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Redox Biol.